Charles Schwab Investment Management Inc Care Dx, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 511,922 shares of CDNA stock, worth $9.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
511,922
Previous 499,480
2.49%
Holding current value
$9.81 Million
Previous $15.6 Million
29.71%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$93.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$51 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$46.2 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$42.3 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.02B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...